Mesa Laboratories Stock Performance
| MLAB Stock | USD 81.58 0.14 0.17% |
Mesa Laboratories has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.57, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. Mesa Laboratories right now secures a risk of 2.98%. Please verify Mesa Laboratories treynor ratio, downside variance, kurtosis, as well as the relationship between the value at risk and expected short fall , to decide if Mesa Laboratories will be following its current price movements.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Mesa Laboratories are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Mesa Laboratories may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
Actual Historical Performance (%)
One Day Return (1.14) | Five Day Return (6.07) | Year To Date Return 2.88 | Ten Year Return (14.87) | All Time Return 2.6 K |
Forward Dividend Yield 0.0078 | Payout Ratio | Forward Dividend Rate 0.64 | Dividend Date 2026-03-16 | Ex Dividend Date 2026-02-27 |
1 | Mesa Laboratories to Release Earnings on Thursday - MarketBeat | 10/30/2025 |
2 | How Mesa Laboratories Inc. stock reacts to Fed tightening - Sell Signal Fast Exit and Entry Strategy Plans - newser.com | 11/18/2025 |
3 | Heres How the Acquisition Helps FTAI Infrastructure | 11/25/2025 |
4 | Disposition of 2000 shares by Sullivan John James of Mesa Laboratories subject to Rule 16b-3 | 12/02/2025 |
5 | Kennedy Capital Management LLC Cuts Stake in Mesa Laboratories, Inc. MLAB | 12/05/2025 |
| Mesa Laboratories dividend paid on 15th of December 2025 | 12/15/2025 |
6 | Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 | 12/19/2025 |
7 | Insiders Who Sold Mesa Laboratories Missed Out On 11 percent Stock Increase | 01/06/2026 |
8 | Mesa Laboratories To Go Ex-Dividend On February 27th, 2026 With 0.16 USD Dividend Per Share - | 01/09/2026 |
9 | Volume Summary Why retail investors favor Mesa Laboratories Inc stock - 2025 Biggest Moves Daily Growth Stock Investment Tips - moha.gov.vn | 01/13/2026 |
| Begin Period Cash Flow | 28.2 M | |
| Total Cashflows From Investing Activities | -4.5 M |
Mesa Laboratories Relative Risk vs. Return Landscape
If you would invest 7,656 in Mesa Laboratories on October 29, 2025 and sell it today you would earn a total of 502.00 from holding Mesa Laboratories or generate 6.56% return on investment over 90 days. Mesa Laboratories is currently generating 0.1471% in daily expected returns and assumes 2.9826% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Mesa, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mesa Laboratories Target Price Odds to finish over Current Price
The tendency of Mesa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 81.58 | 90 days | 81.58 | about 29.46 |
Based on a normal probability distribution, the odds of Mesa Laboratories to move above the current price in 90 days from now is about 29.46 (This Mesa Laboratories probability density function shows the probability of Mesa Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.57 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Mesa Laboratories will likely underperform. Additionally Mesa Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Mesa Laboratories Price Density |
| Price |
Predictive Modules for Mesa Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mesa Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mesa Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mesa Laboratories is not an exception. The market had few large corrections towards the Mesa Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mesa Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mesa Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | 1.57 | |
σ | Overall volatility | 4.50 | |
Ir | Information ratio | 0.01 |
Mesa Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mesa Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mesa Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 152.44 M. | |
| Over 93.0% of the company shares are owned by institutional investors | |
| On 15th of December 2025 Mesa Laboratories paid $ 0.16 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Volume Summary Why retail investors favor Mesa Laboratories Inc stock - 2025 Biggest Moves Daily Growth Stock Investment Tips - moha.gov.vn |
Mesa Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mesa Stock often depends not only on the future outlook of the current and potential Mesa Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mesa Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.4 M | |
| Cash And Short Term Investments | 27.3 M |
Mesa Laboratories Fundamentals Growth
Mesa Stock prices reflect investors' perceptions of the future prospects and financial health of Mesa Laboratories, and Mesa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mesa Stock performance.
| Return On Equity | -0.0093 | ||||
| Return On Asset | 0.0213 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 621.29 M | ||||
| Shares Outstanding | 5.52 M | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 2.53 X | ||||
| Price To Sales | 1.84 X | ||||
| Revenue | 240.98 M | ||||
| Gross Profit | 152.44 M | ||||
| EBITDA | 42.35 M | ||||
| Net Income | (1.97 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 181.47 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 32.38 X | ||||
| Cash Flow From Operations | 46.81 M | ||||
| Earnings Per Share | (0.31) X | ||||
| Market Capitalization | 451.28 M | ||||
| Total Asset | 433.35 M | ||||
| Retained Earnings | (188.94 M) | ||||
| Working Capital | (61.28 M) | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
About Mesa Laboratories Performance
By analyzing Mesa Laboratories' fundamental ratios, stakeholders can gain valuable insights into Mesa Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mesa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mesa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 118.16 | 208.66 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Mesa Laboratories performance evaluation
Checking the ongoing alerts about Mesa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mesa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 152.44 M. | |
| Over 93.0% of the company shares are owned by institutional investors | |
| On 15th of December 2025 Mesa Laboratories paid $ 0.16 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Volume Summary Why retail investors favor Mesa Laboratories Inc stock - 2025 Biggest Moves Daily Growth Stock Investment Tips - moha.gov.vn |
- Analyzing Mesa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mesa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Mesa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mesa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mesa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mesa Laboratories' stock. These opinions can provide insight into Mesa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance |